Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-21-001, Promoting the Importance of Infant and Childhood Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA-IP-21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines To Prevent Enteric and Respiratory Viruses in Children; Amended Notice of Meeting, 15671 [2021-06006]

Download as PDF Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices Hearings Division of the Enforcement Bureau at (202) 418–1420. Such service copy shall be addressed to the named counsel of record, Investigations & Hearings Division, Enforcement Bureau, Federal Communications Commission, 45 L Street NE, Washington, DC 20554. 16. It is further ordered that the parties to the captioned applications shall, pursuant to section 311(a)(2) of the Communications Act of 1934, as amended, and section 73.3594 of the Commission’s Rules, give notice of the hearing within the time and in the manner prescribed in such Rule, and shall advise the Commission of the satisfaction of such requirements as mandated by section 73.3594 of the Commission’s Rules. 17. It is further ordered that copies of this Hearing Designation Order, Order to Show Cause and Notice of Opportunity for Hearing shall be sent via Certified Mail, Return Receipt Requested, and by regular first-class mail to Michael G. Hubbard, Auburn Network, Inc., P.O. Box 950, Auburn, AL 36831, and M. Scott Johnson, 5028 Wisconsin Avenue NW, Suite 301, Washington, DC 20016. 18. It is further ordered that the Secretary of the Commission shall cause to have this Hearing Designation Order, Order to Show Cause and Notice of Opportunity for Hearing or a summary thereof published in the Federal Register. Federal Communications Commission. Thomas Horan, Chief of Staff, Media Bureau. Parties: Neptune Pacific Direct Line Pte. Ltd. and Pacific Forum Line (Group) Limited. Filing Party: David Monroe; GKG Law. Synopsis: The amendment updates the commencement date of the slot charter arrangement. Proposed Effective Date: 3/17/2021. Location: https://www2.fmc.gov/ FMC.Agreements.Web/Public/ AgreementHistory/39509. Agreement No.: 201356–001. Agreement Name: PFLG/NPDL Slot Charter Agreement. Parties: Neptune Pacific Direct Line Pte. Ltd. and Pacific Forum Line (Group) Limited. Filing Party: David Monroe; GKG Law. Synopsis: The amendment updates the commencement date of the slot charter arrangement. Proposed Effective Date: 3/17/2021. Location: https://www2.fmc.gov/ FMC.Agreements.Web/Public/ AgreementHistory/39510. Agreement No.: 201358–001. Agreement Name: NPDL/ANLS Slot Charter Agreement. Parties: Neptune Pacific Direct Line Pte. Ltd. and ANL Singapore Pte Ltd. Filing Party: David Monroe; GKG Law. Synopsis: The amendment updates the commencement date of the slot charter arrangement. Proposed Effective Date: 3/17/2021. Location: https://www2.fmc.gov/ FMC.Agreements.Web/Public/ AgreementHistory/40502. Dated: March 19, 2021. Rachel E. Dickon, Secretary. [FR Doc. 2021–05983 Filed 3–23–21; 8:45 am] BILLING CODE 6712–01–P [FR Doc. 2021–06098 Filed 3–23–21; 8:45 am] FEDERAL MARITIME COMMISSION Billing Code 3760–02 khammond on DSKJM1Z7X2PROD with NOTICES Notice of Agreements Filed The Commission hereby gives notice of the filing of the following agreements under the Shipping Act of 1984. Interested parties may submit comments, relevant information, or documents regarding the agreements to the Secretary by email at Secretary@ fmc.gov, or by mail, Federal Maritime Commission, Washington, DC 20573. Comments will be most helpful to the Commission if received within 12 days of the date this notice appears in the Federal Register. Copies of agreements are available through the Commission’s website (www.fmc.gov) or by contacting the Office of Agreements at (202) 523– 5793 or tradeanalysis@fmc.gov. Agreement No.: 201355–001. Agreement Name: NPDL/PFLG Slot Charter Agreement. VerDate Sep<11>2014 16:30 Mar 23, 2021 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–IP–21– 001, Promoting the Importance of Infant and Childhood Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA–IP–21–002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines To Prevent Enteric and Respiratory Viruses in Children; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 15671 and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– IP–21–001, Promoting the Importance of Infant and Childhood Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA–IP–21–002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children; April 13–14, 2021, 10 a.m.–5 p.m., EDT, Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Boulevard, Atlanta, Georgia 30329–4027. The meeting was published in the Federal Register on January 11, 2021, Volume 86, Number 6, page 1976. The meeting is being amended to change the title and meeting date of the special emphasis panel from RFA–IP– 21–001, Promoting the Importance of Infant and Childhood Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA–IP–21–002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children; April 13–14, 2021, 10 a.m.–5 p.m., EDT to RFA–IP–21–001, Promoting the Importance of Infant and Childhood Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA–IP–21–003, Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID–19), and Other Respiratory Pathogens in South Africa; May 13, 2021, 10 a.m.–5 p.m., EDT. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027, (404) 718– 8833, ganderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–06006 Filed 3–23–21; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06006]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP-21-001, Promoting the Importance of Infant 
and Childhood Vaccination Among Pregnant Women by Prenatal Care 
Providers; and RFA-IP-21-002, US Enhanced Surveillance Network to 
Assess Burden, Natural History, and Effectiveness of Vaccines To 
Prevent Enteric and Respiratory Viruses in Children; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP-21-001, Promoting the Importance of Infant and Childhood 
Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA-
IP-21-002, US Enhanced Surveillance Network to Assess Burden, Natural 
History, and Effectiveness of Vaccines to Prevent Enteric and 
Respiratory Viruses in Children; April 13-14, 2021, 10 a.m.-5 p.m., 
EDT, Teleconference, Centers for Disease Control and Prevention, Room 
1080, 8 Corporate Square Boulevard, Atlanta, Georgia 30329-4027. The 
meeting was published in the Federal Register on January 11, 2021, 
Volume 86, Number 6, page 1976.
    The meeting is being amended to change the title and meeting date 
of the special emphasis panel from RFA-IP-21-001, Promoting the 
Importance of Infant and Childhood Vaccination Among Pregnant Women by 
Prenatal Care Providers; and RFA-IP-21-002, US Enhanced Surveillance 
Network to Assess Burden, Natural History, and Effectiveness of 
Vaccines to Prevent Enteric and Respiratory Viruses in Children; April 
13-14, 2021, 10 a.m.-5 p.m., EDT to RFA-IP-21-001, Promoting the 
Importance of Infant and Childhood Vaccination Among Pregnant Women by 
Prenatal Care Providers; and RFA-IP-21-003, Collaborative Research on 
Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory 
Pathogens in South Africa; May 13, 2021, 10 a.m.-5 p.m., EDT. The 
meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, (404) 718-8833, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-06006 Filed 3-23-21; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.